Intrathecal Drug Delivery for Pain and Spasticity

Dr. Diwan is a world renown luminary in Minimally Invasive Spine Methods. A former fellowship director, at Cornell University, Dr. Diwan now leads the Latin American Pain Society and the New York New Jersey Pain Symposium, one of the premier meetings in the space. In addition, he has authored hundreds of articles, chapters and books. Dr. Deer and Dr. Diwan frequently teach these methods of Minimally Invasive Spine surgery around the world and have an extensive network of physicians who are renowned in all areas of the book. Timothy R. Deer is a clinical professor of anesthesiology at the West Virginia University School of Medicine, where he also received his medical degree. He completed his training in anesthesiology and pain medicine at the University of Virginia. Dr. Deer has published on a range of topics, including injection techniques, minimally invasive disc procedures, intrathecal drug delivery, and spinal cord and peripheral nerve stimulation. He lectures at many national and international symposiums and has been involved in the hands-on training of more than a thousand interventional pain specialists. He serves on the board of directors of the North American Neuromodulation Society and American Academy of Pain Medicine. He is a past chair of the committee on pain medicine of the American Society of Anesthesiologists, a member of the editorial board of the journal Neuromodulation, president of the West Virginia Society of Interventional Pain Physicians, and serves on several other boards and committees.

• SECTION I: General Considerations1. Basic Science of Spinal Receptors2. Pharmacologic Agents and Compounding of Intrathecal Drugs3. Polyanalgesia for Implantable Drug Delivery Systems4. Principles of Patient Management for Intrathecal Analgesia5. Patient Selection for Intrathecal Infusion to Treat Chronic Pain6. Patient Preparation7. Psychological Considerations in IDD8. Intrathecal Drug Delivery: Medical Necessity, Documentation, Coding and BillingSECTION II: Implant Devices9. Methods of Trials for Consideration of ITDDS10. Techniques of Implant Placement for Intrathecal Pumps11. Programmable versus Fixed-Rate Pumps for Intrathecal Drug Delivery12. SynchroMed EL vs SynchroMed II13. Minimizing the Risks of Intrathecal Therapy14. Complications Associated with Intrathecal Drug Delivery SystemsSECTION III: Evidence-based practice15. Management of ITDDS in Patients with Co-Morbidities16. Cost-Effectiveness of Implanted Drug Delivery Systems17. Neuroaugmentation by Stimulation vs. Intrathecal Drug Delivery Systems18. Anticoagulation guidelines and Intrathecal Drug Delivery Systems19. Intrathecal Therapy for Malignant PainSECTION IV: ITDDs for spasticity20. Intrathecal Baclofen Trialing21. Baclofen Pump ManagementSECTION V: Future of ITDDs22. Future of Intrathecal Drug Delivery Systems (including new devices)23. Trialing for Ziconotide Intrathecal Analgesic Therapy24. Perioperative Management of Patients with ITDDS